Jefferies has selected Biren Amin as managing director and senior equity research analyst for its biotechnology companies. He joins the bank from WJB Capital Group. In his previous role, Amin was serving as equity research analyst. Before that, he was with FTN Equity Markets, Stanford Financial, Prudential Equity Group and Aventis Pharmaceuticals.
Click here for the release from Business Wire.